|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 413/14 | |||
| A61K 31/5377 | |||
| A61P 3/06 |
| (11) | Patento numeris | 2463282 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11188373.2 |
| Europos patento paraiškos padavimo data | 2008-11-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 985456 P | 2007-11-05 | US |
| (72) |
Mogi, Muneto, US
Yamada, Ken, US
Yasoshima, Kayo, US
Kawanami, Toshio, US
Umemura, Ichiro, JP
Iwaki, Yuki, US
Qin, Hongbo, JP
Imase, Hidetomo, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |